Filing Details
- Accession Number:
- 0001127602-12-003341
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-01 15:19:06
- Reporting Period:
- 2012-01-31
- Filing Date:
- 2012-02-01
- Accepted Time:
- 2012-02-01 15:19:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 799729 | Parexel International Corp | PRXL | Services-Commercial Physical & Biological Research (8731) | 042776269 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1303069 | Arthur Kurt Brykman | Parexel International Corporation 195 West Street Waltham MA 02451 | President, Pcms | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-01-31 | 63,859 | $10.00 | 160,136 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-01-31 | 36,859 | $23.03 | 123,277 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-01-31 | 27,000 | $23.90 | 96,277 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-01-31 | 63,859 | $0.00 | 63,859 | $10.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2012-09-08 | No | 4 | M | Direct |
Footnotes
- The reported sale was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2011.
- This transaction was executed in multiple trades through a trade order executed by a broker-dealer at prices ranging from $22.75- $23.68. The price reported in this column reflects the weighted average sale price. For all transactions reported on this Form 4 utilizing a weighted average price, the reporting person will provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price.
- This transaction was executed in multiple trades through a trade order executed by a broker-dealer at prices ranging from $23.76- $23.99. The price reported in this column reflects the weighted average sale price. For all transactions reported on this Form 4 utilizing a weighted average price, the reporting person will provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price.
- Currently exercisable
Billionaire Hedge Funds
